These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15856381)

  • 1. Investigation of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Yanagisawa C; Uehara K; Matsui H; Yamaguchi Y; Hososaka Y; Barada K; Sakai F; Itabashi Y; Ikeda S; Atsuda K; Tanaka H; Inamatsu T; Nagayama A; Sunakawa K
    J Infect Chemother; 2005 Apr; 11(2):104-6. PubMed ID: 15856381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological investigation of "beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)"].
    Hanaki H; Yamaguchi Y
    Kansenshogaku Zasshi; 2003 Jul; 77(7):499-504. PubMed ID: 12931576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin].
    Yamaguchi Y; Hanaki H; Barada K; Inamatu T; Sunakawa K
    Kansenshogaku Zasshi; 2003 Sep; 77(9):661-6. PubMed ID: 14574841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method of detecting beta-lactam antibiotic induced vancomycin resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Nomura S; Haraga I; Nagayama A; Sunakawa K
    Int J Antimicrob Agents; 2004 Jan; 23(1):1-5. PubMed ID: 14732306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX].
    Hososaka Y; Hanaki H; Hayashi I; Kamibeppu K; Sunakawa K
    Kansenshogaku Zasshi; 2004 Aug; 78(8):717-21. PubMed ID: 15478647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.
    Hanaki H; Cui L; Ikeda-Dantsuji Y; Nakae T; Honda J; Yanagihara K; Takesue Y; Matsumoto T; Sunakawa K; Kaku M; Tomono K; Fukuchi K; Kusachi S; Mikamo H; Takata T; Otsuka Y; Nagura O; Fujitani S; Aoki Y; Yamaguchi Y; Tateda K; Kadota J; Kohno S; Niki Y
    J Infect Chemother; 2014 Sep; 20(9):527-34. PubMed ID: 25066429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
    J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR).
    Hososaka Y; Hanaki H; Yanagisawa C; Yamaguchi Y; Matsui H; Nakae T; Iwata S; Hayashi I; Sunakawa K
    J Infect Chemother; 2006 Aug; 12(4):181-4. PubMed ID: 16944255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance.
    Hirao Y; Ikeda-Dantsuji Y; Matsui H; Yoshida M; Hori S; Sunakawa K; Nakae T; Hanaki H
    BMC Microbiol; 2012 May; 12():69. PubMed ID: 22568976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
    Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Roch M; Clair P; Renzoni A; Reverdy ME; Dauwalder O; Bes M; Martra A; Freydière AM; Laurent F; Reix P; Dumitrescu O; Vandenesch F
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5306-14. PubMed ID: 24957836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"].
    Hanaki H
    Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of the active component that induces vancomycin resistance in MRSA.
    Ikeda S; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Matsui H; Iwatsuki M; Shiomi K; Nakae T; Sunakawa K; Omura S
    J Antibiot (Tokyo); 2010 Sep; 63(9):533-8. PubMed ID: 20588304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Hatano K; Yokota Y; Hanaki H; Sunakawa K
    Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Barata K; Sakai H; Sunakawa K
    Int J Antimicrob Agents; 2004 Mar; 23(3):311-3. PubMed ID: 15164976
    [No Abstract]   [Full Text] [Related]  

  • 17. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance.
    Yanagisawa C; Hanaki H; Matsui H; Ikeda S; Nakae T; Sunakawa K
    Antimicrob Agents Chemother; 2009 Jan; 53(1):63-8. PubMed ID: 18936187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
    Yanagisawa C; Hanaki H; Oishi T; Uehara K; Yamaguchi Y; Matui H; Sunakawa K
    Jpn J Antibiot; 2005 Feb; 58(1):11-6. PubMed ID: 15847221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
    Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.